Clinical status of at-risk individuals 5 years later: further validation of the psychometric high-risk strategy.
about
Developing psychosis and its risk states through the lens of schizotypy.Schizotypy: looking back and moving forwardSchizotypy as an organizing framework for social and affective sciencesThe clinical basis of orthorexia nervosa: emerging perspectivesCognition and brain function in schizotypy: a selective review.The neural basis of theory of mind and its relationship to social functioning and social anhedonia in individuals with schizophrenia.Anhedonia in schizophrenia: a review of assessment strategiesDevelopment of a computerized adaptive test for Schizotypy assessmentSex differences in Wisconsin Schizotypy Scales--a meta-analysis.Worries about being judged versus being harmed: disentangling the association of social anxiety and paranoia with schizotypy.Behavioral signs of schizoidia and schizotypy in the biological parents of social anhedonics.Sex differences in magical ideation: a community-based twin studyDevelopmental instability in social anhedonia: an examination of minor physical anomalies and clinical characteristicsSchizotypal, schizoid and paranoid characteristics in the biological parents of social anhedonics.Correspondence between psychometric and clinical high risk for psychosis in an undergraduate population.Aberrant asociality: how individual differences in social anhedonia illuminate the need to belong.Is social anhedonia related to emotional responsivity and expressivity? A laboratory study in women.Neuropsychological functioning and social anhedonia: three-year follow-up data from a longitudinal community high risk study.Experience of pleasure and emotional expression in individuals with schizotypal personality features.Reconceptualizing anhedonia: novel perspectives on balancing the pleasure networks in the human brainLatent factor modeling of four schizotypy dimensions with theory of mind and empathyPerceived threat mediates the relationship between psychosis proneness and aggressive behavior.Inferring about individual drug and schizotypy effects on cognitive functioning in polydrug using mephedrone users before and after clubbing.Social anhedonia and schizotypy in a community sample: the Maryland longitudinal study of schizotypyThe challenges of fitting an item response theory model to the Social Anhedonia Scale.Developmental trajectories of schizotypal personality disorder-like behavioural manifestations: a two-year longitudinal prospective study of college studentsTesting measurement invariance of the schizotypal personality questionnaire-brief scores across Spanish and Swiss adolescents.Hemispheric language asymmetry in first episode psychosis and schizotypy: the role of cannabis consumption and cognitive disorganizationMotivation and effort in individuals with social anhedonia.Unpleasant and Pleasant Referential Thinking: Relations with Self- Processing, Paranoia, and Other Schizotypal TraitsSocial networking profile correlates of schizotypyRates of avoidant, schizotypal, schizoid and paranoid personality disorders in psychometric high-risk groups at 5-year follow-upExamining associations between psychosis risk, social anhedonia, and performance of striatum-related behavioral tasks.Neural correlates of reward processing in healthy siblings of patients with schizophrenia.Social anhedonia and affiliation: examining behavior and subjective reactions within a social interaction.The validity of Psychosis Proneness Scales as vulnerability indicators in recent-onset schizophrenia patients.Anhedonia in the psychosis risk syndrome: associations with social impairment and basal orbitofrontal cortical activity.Cognitive correlates of schizophrenia signs and symptoms: II. Emotional disturbancesEvidence of structural invariance across three groups of Meehlian schizotypes.A comprehensive review of auditory verbal hallucinations: lifetime prevalence, correlates and mechanisms in healthy and clinical individuals.
P2860
Q26822553-8D857960-3CA3-482C-8DAF-C1573A330682Q26852958-81D25220-11B0-4178-B0ED-FE0C99ED384EQ27011733-1DB7B063-9622-41A7-9A0B-F0AAF6E71EFEQ27025644-6ABCE076-07A6-4402-B45B-67DF440D8556Q30389966-44C4FF5D-0F58-4CBF-B7FC-3460AA30821DQ30445421-26094226-66EC-442A-B1F9-65F5B8B03A5FQ30491345-372EDD9B-FB25-441C-BA6F-0816971D86ABQ31137391-7C618DB0-0278-40D5-B4AF-316514B75119Q33707620-A46FF0AF-24F1-4A65-9DA5-19C421B14476Q33734099-987AFC43-5953-450D-A069-9D7458A1EF00Q33767836-AD0216EC-4E93-4601-A47E-F7AD3CE4E0F3Q33783996-0342C7E6-3B3F-4450-BDEC-44E2BECE869AQ33798478-B6522C6E-3BC4-40E9-ABB2-E64741760655Q34037306-93562481-6327-4C36-874D-335F4115CB14Q34122956-F3682024-F145-41B8-A309-185DDC8E7E75Q34177307-29104D4C-C7B1-4F36-8ADB-16A9A0E1EA98Q34233245-1B237A92-8848-4980-A32C-CE82AF5820FFQ34234494-3EEA5E29-942E-4D1D-99F1-EB1C83A68554Q34277161-E16575FE-0B9D-4C8D-AEB6-2A88EBF7AF11Q34468910-5C8CEBBA-2F81-4DA1-BC75-AC7A6B45F1ECQ34557235-86031A1C-E93F-47D8-A13D-B30B8EDB871BQ34586694-37DAC306-17D3-411F-97DA-BE9FF58562C8Q34637364-F5D4406F-D224-4336-BF78-D54AB4E5B36CQ34830420-768B543E-241C-486C-84EF-F308A2560794Q35051715-7CD8C8EC-F13E-4475-AFA4-8E10D3CBD26DQ35056687-C9EF75E8-560B-45F6-849B-5631A800F9CBQ35069936-F0AD4E1B-F33B-4279-9FCD-3CD82888826FQ35216772-EBBF9E34-7AED-4F3D-B897-79445EB76763Q35625160-9F409417-76D8-47BC-80A3-8AA8247106E2Q35661528-15E934AC-751F-4B52-826D-339BD1D56802Q35664218-F4445A6B-3E98-4034-AC64-CF3519354991Q36008615-7D066D33-CE52-4D36-9913-CE9AB21B14F1Q36070250-B0F91B7B-4958-4274-8CEA-3B93E819F5A8Q36098112-7D493093-61BA-4DAD-AAA1-0BF44E8DCC24Q36442304-6DB6B325-90A3-4438-BE64-649E137B6570Q36593570-0646D257-9D7D-49C6-848B-62CE9B0C605EQ36848294-1BC16A15-57F7-40FE-93FC-8915E5205D33Q36968915-2CC8C9B6-DA98-486E-B341-26A03D3EF366Q36987078-17088D08-C922-419D-B933-133B345B534BQ37015584-7A718598-9D02-4AF9-8D1B-1D2D9AE75D86
P2860
Clinical status of at-risk individuals 5 years later: further validation of the psychometric high-risk strategy.
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Clinical status of at-risk ind ...... ychometric high-risk strategy.
@ast
Clinical status of at-risk ind ...... ychometric high-risk strategy.
@en
Clinical status of at-risk ind ...... ychometric high-risk strategy.
@nl
type
label
Clinical status of at-risk ind ...... ychometric high-risk strategy.
@ast
Clinical status of at-risk ind ...... ychometric high-risk strategy.
@en
Clinical status of at-risk ind ...... ychometric high-risk strategy.
@nl
prefLabel
Clinical status of at-risk ind ...... ychometric high-risk strategy.
@ast
Clinical status of at-risk ind ...... ychometric high-risk strategy.
@en
Clinical status of at-risk ind ...... ychometric high-risk strategy.
@nl
P2093
P1476
Clinical status of at-risk ind ...... ychometric high-risk strategy.
@en
P2093
Christie W Matts
Diane C Gooding
Kathleen A Tallent
P304
P356
10.1037/0021-843X.114.1.170
P577
2005-02-01T00:00:00Z